*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
Simone Douglas
BME PhD Thesis Defense
Date: April 24th, 2020
Time: 1:00PM
BlueJeans Link: https://primetime.bluejeans.com/a2m/live-event/tpbbpzcy
Advisor:
Manu O. Platt, PhD
Committee Members:
Edward Botchwey, PhD
Johnna Temenoff, PhD
Rodney Averett, PhD (University of Georgia)
Clint Joiner, MD, PhD (Emory University & Children’s Healthcare of Atlanta)
Roger Kamm, PhD (Massachusetts Institute of Technology)
Title: Cathepsin-Mediated Fibrin(ogen)olysis in Engineered Microvascular Networks and Chronic Coagulation in Sickle Cell Disease
Abstract:
Cysteine cathepsins are powerful proteases involved in tissue destructive disease progression, including angiogenesis and pathogenic vascular remodeling. However, some of their functions and mechanisms in biological processes remains unclear. For example, their potential role in polymerizing and degrading fibrin, an essential blood clotting protein and biomaterial scaffold for tissue repair, is not well characterized. The central hypothesis of this dissertation is that cysteine cathepsins have fibrin(ogen)olytic properties which can facilitate fibrin matrix remodeling. To identify the role of cathepsin-mediated fibrin(ogen)olysis we investigated, firstly, fibrin-based constructs as a biological mimicking test bed and secondly, sickle cell disease for a pathological condition. Our results show that fibrin is a novel substrate for human cysteine cathepsins, with unique properties to sustain activity over extended periods of time. This work contributes to our understanding of the role of cathepsin-mediated fibrin degradation in vitro and how cathepsins remodel matrix of microvascular networks, as well as identifying cathepsin involvement in chronic coagulation activation in sickle cell anemia.
